Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Amid India’s shifting economic landscape, sectoral mutual funds offer sharp, theme-based exposure. This article breaks down ...

While US exceptionalism may have lost some of its shine, it is worth remembering that the US stock market remains home to ...

British American Tobacco Bangladesh Company Limited (BATBC) has decided to invest Tk297 crore in its Savar factory. In a disclosure on the Dhaka Stock Exchange's  website it was said the Board of ...

With strong fundamentals and reliable payouts, these two dividend stocks could help you grow your portfolio reliably over ...

The S&P 500 (^GSPC) flirted with all-time highs but ended the day nearly flat, just shy of its record level. Nvidia shares ...

Certified financial planners and other wealth managers discuss the pros and cons of certificates of deposit and whether or ...

The US dollar is having its worst year in decades. While stocks have recovered from their April lows and demand for bonds has been relatively steady, the dollar has continued a precipitous decline.

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

SoFi reports 68% of investors plan to shift strategies in 2025, with 87% having invested in the past year, reflecting strong ...

Mark Minervini is an accomplished stock trader known for his disciplined approach, his consistently high returns and his proprietary Specific Entry Point Analysis methodology. He's advised hedge funds ...

Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and ...